Mostra i principali dati dell'item

dc.contributor.authorDíaz López, David 
dc.contributor.authorPiquer Gil, Marina
dc.contributor.authorSánchez Recio, Javier
dc.contributor.authorMartínez Losa, María Magdalena
dc.contributor.authorAlonso Peña, José Ramón 
dc.contributor.authorWeruaga Prieto, Eduardo 
dc.contributor.authorÁlvarez Dolado, Manuel
dc.date.accessioned2026-01-21T09:50:33Z
dc.date.available2026-01-21T09:50:33Z
dc.date.issued2017
dc.identifier.citationDíaz, D., Piquer‐Gil, M., Recio, J. S., Martínez‐Losa, M. M., Alonso, J. R., Weruaga, E., y Álvarez‐Dolado, M. (2018). Bone marrow transplantation improves motor activity in a mouse model of ataxia. Journal of Tissue Engineering and Regenerative Medicine, 12(4), e1950-e1961. https://doi.org/10.1002/term.2626es_ES
dc.identifier.urihttp://hdl.handle.net/10366/169116
dc.description.abstract[EN] Ataxias are locomotor disorders that can have an origin both neural and muscular, although both impairments are related. Unfortunately, ataxia has no cure, and the current therapies are aimed at motor re-education or muscular reinforcement. Nevertheless, cell therapy is becoming a promising approach to deal with incurable neural diseases, including neuromuscular ataxias. Here, we have used a model of ataxia, the Purkinje Cell Degeneration (PCD) mutant mouse, to study the effect of healthy (wild-type) bone marrow transplantation on the restoration of defective mobility. Bone marrow transplants (from both mutant and healthy donors) were performed in wild-type and PCD mice. Then, a wide battery of behavioural tests was employed to determine possible motor amelioration in mutants. Finally, cerebellum, spinal cord, and muscle were analysed to study the integration of the transplant-derived cells and the origin of the behavioural changes. Our results demonstrated that the transplant of wild-type bone marrow restores the mobility of PCD mice, increasing their capabilities of movement (52-100% of recovery), exploration (20-71% of recovery), speed (35% of recovery), and motor coordination (25% of recovery). Surprisingly, our results showed that bone marrow transplant notably improves the skeletal muscle structure, which is severely damaged in the mutants, rather than ameliorating the central nervous system. Although a multimodal effect of the transplant is not discarded, muscular improvements appear to be the basis of this motor recovery. Furthermore, the results from our study indicate that bone marrow stem cell therapy can be a safe and effective alternative for dealing with movement disorders such as ataxias.es_ES
dc.description.sponsorshipThis work was supported by the Fondo de Investigaciones Sanitarias (FIS 04/2744), the Ministerio de Ciencia e Innovación (BFU2010-18284), the Ministerio de Economía y Competitividad (SAF2013-41175R), the Generalitat Valenciana (ACOMP06/131), the Junta de Castilla y León, the Junta de Andalucía (PI-0736-2010), the Centre for Regenerative Medicine and Cell Therapy of Castilla y León, the Samuel Solórzano Foundation, the FOLTRA Foundation, the Mututa Madrileña (MMA) Foundation, the Colectivo Ataxias en Movimiento Foundation, the Alicia Koplowitz Foundation, and the University of Salamanca.es_ES
dc.format.mimetypeapplicatio/pdf
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectBone marrow transplantationes_ES
dc.subjectAtaxiaes_ES
dc.subjectMotor activityes_ES
dc.subjectDisease modelses_ES
dc.subjectMutant strainses_ES
dc.subject.meshAllografts *
dc.subject.meshAtaxia *
dc.subject.meshMotor Activity *
dc.subject.meshAnimals *
dc.subject.meshBone Marrow Transplantation *
dc.subject.meshMice *
dc.titleBone marrow transplantation improves motor activity in a mouse model of ataxia.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1002/term.2626es_ES
dc.subject.unesco3213.14 Cirugía de Los Trasplanteses_ES
dc.subject.unesco3205.07 Neurologíaes_ES
dc.identifier.doi10.1002/term.2626
dc.relation.projectIDFIS 04/2744es_ES
dc.relation.projectIDBFU2010-18284es_ES
dc.relation.projectIDSAF2013-41175Res_ES
dc.relation.projectIDACOMP06/131es_ES
dc.relation.projectIDPI-0736-2010es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.pmid29222849
dc.identifier.essn1932-7005
dc.journal.titleJournal of tissue engineering and regenerative medicinees_ES
dc.volume.number12es_ES
dc.issue.number4es_ES
dc.page.initiale1950es_ES
dc.page.finale1961es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsanimales *
dc.subject.decsataxia *
dc.subject.decsactividad motora *
dc.subject.decsratones *
dc.subject.decsaloinjertos *
dc.subject.decstrasplante de médula ósea *


Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International